Cargando…

A Pathway for Community-Acquired Pneumonia With Rapid Conversion to Oral Therapy Improves Health Care Value

BACKGROUND: Evidence supports streamlined approaches for inpatients with community-acquired pneumonia (CAP) including early transition to oral antibiotics and shorter therapy. Uptake of these approaches is variable, and the best approaches to local implementation of infection-specific guidelines are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ciarkowski, Claire E, Timbrook, Tristan T, Kukhareva, Polina V, Edholm, Karli M, Hatton, Nathan D, Hopkins, Christy L, Thomas, Frank, Sanford, Matthew N, Igumnova, Elena, Benefield, Russell J, Kawamoto, Kensaku, Spivak, Emily S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Major Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686657/ https://www.ncbi.nlm.nih.gov/pubmed/33269294 http://dx.doi.org/10.1093/ofid/ofaa497

Ejemplares similares

524. The Journey to Implement a Computerized Clinical Decision Support (CDS) Tool to Improve Testing for Clostridium difficile Infection (CDI)
por: Mayer, Jeanmarie, et al.
Publicado: (2018)

Impact of an Antimicrobial Stewardship Bundle for Uncomplicated Gram-Negative Bacteremia
por: Erickson, Reaghan M, et al.
Publicado: (2019)

Impact of a Multiplex PCR Assay for Bloodstream Infections With and Without Antimicrobial Stewardship Intervention at a Cancer Hospital
por: Buss, Brian A, et al.
Publicado: (2018)

Epidemiology of Antimicrobial Resistance Among Blood and Respiratory Specimens in the United States Using Genotypic Analysis From a Cloud-Based Population Surveillance Network
por: Timbrook, Tristan T, et al.
Publicado: (2022)

Epidemiology and Outcomes of Community-Acquired Escherichia coli Pneumonia
por: John, Teny M, et al.
Publicado: (2021)

Community-Acquired Pneumonia in the Immunocompromised Host: Epidemiology and Outcomes
por: Ramirez, Julio A, et al.
Publicado: (2023)

Normal Respiratory Flora as a Cause of Community-Acquired Pneumonia
por: Musher, Daniel M, et al.
Publicado: (2020)

Hepcidin and Ferritin Predict Microbial Etiology in Community-Acquired Pneumonia
por: Oppen, Kjersti, et al.
Publicado: (2021)

Community-Acquired Pneumonia in Canada During Coronavirus Disease 2019
por: Mandell, Lionel A, et al.
Publicado: (2022)

Molecular Detection and Characterization of Mycoplasma pneumoniae Among Patients Hospitalized With Community-Acquired Pneumonia in the United States
por: Diaz, Maureen H., et al.
Publicado: (2015)

Procalcitonin as a Marker of Etiology in Adults Hospitalized With Community-Acquired Pneumonia
por: Self, Wesley H., et al.
Publicado: (2017)

Clinical Features and Outcomes of Community-Acquired Pneumonia Caused by Haemophilus influenzae
por: Shoar, Saeed, et al.
Publicado: (2021)

Lymphopenia Is Associated With Poor Outcomes of Patients With Community-Acquired Pneumonia and Sepsis
por: Cilloniz, Catia, et al.
Publicado: (2021)

Improved Diagnostics Help to Identify Clinical Features and Biomarkers That Predict Mycoplasma pneumoniae Community-acquired Pneumonia in Children
por: Meyer Sauteur, Patrick M, et al.
Publicado: (2019)

Minimizing Time to Optimal Antimicrobial Therapy for Enterobacteriaceae Bloodstream Infections: A Retrospective, Hypothetical Application of Predictive Scoring Tools vs Rapid Diagnostics Tests
por: Cwengros, Laura N, et al.
Publicado: (2020)

1407. Disproportionality Analysis of Safety with Nafcillin and Oxacillin with the FDA Adverse Event Reporting System (FAERS)
por: Timbrook, Tristan T, et al.
Publicado: (2018)

Incidence, Etiology, and Outcomes of Community-Acquired Pneumonia: A Population-Based Study
por: Bjarnason, Agnar, et al.
Publicado: (2018)

Antibiotic Use and Outcomes in Young Children Hospitalized With Uncomplicated Community-Acquired Pneumonia
por: Hofto, Meghan E, et al.
Publicado: (2022)

A Quality Initiative to Improve Postdischarge Care for Patients on Outpatient Parenteral Antimicrobial Therapy
por: Certain, Laura K, et al.
Publicado: (2022)

Effects of a Syndrome-Specific Antibiotic Stewardship Intervention for Inpatient Community-Acquired Pneumonia
por: Haas, Michelle K., et al.
Publicado: (2016)

Incidence and Predictors of Community-Acquired Pneumonia in Patients With Hematological Cancers Between 2016 and 2019( )
por: Certan, Maria, et al.
Publicado: (2022)

Diagnostic and antimicrobial stewardship workforce challenges: A crisis in combating antimicrobial resistance
por: Timbrook, Tristan T., et al.
Publicado: (2023)

Impact of Streptococcus pneumoniae Urinary Antigen Testing in Patients With Community-Acquired Pneumonia Admitted Within a Large Academic Health System
por: Greenfield, Adam, et al.
Publicado: (2021)

Development of an Electronic Algorithm to Identify in Real Time Adults Hospitalized With Suspected Community-Acquired Pneumonia
por: Jones, George, et al.
Publicado: (2021)

Low Levels of Immunoglobulins and Mannose-Binding Lectin Are Not Associated With Etiology, Severity, or Outcome in Community-Acquired Pneumonia
por: Siljan, William W, et al.
Publicado: (2018)

Bacteremic Community-Acquired Pneumonia in Ethiopian Children: Etiology, Antibiotic Resistance, Risk Factors, and Clinical Outcome
por: Negash, Abel Abera, et al.
Publicado: (2019)

2375. Skin and Soft-Tissue Infections in Patients With Obesity or Heart Failure
por: Ihm, Claudia, et al.
Publicado: (2018)

Adherence to Treatment Guideline Improves Patient Outcomes in a Prospective Cohort of Adults Hospitalized for Community-Acquired Pneumonia
por: Lui, Grace, et al.
Publicado: (2020)

Host Inflammatory Biomarkers of Disease Severity in Pediatric Community-Acquired Pneumonia: A Systematic Review and Meta-analysis
por: Fernandes, Catarina D, et al.
Publicado: (2019)

A Phase 3 Study to Compare Delafloxacin With Moxifloxacin for the Treatment of Adults With Community-Acquired Bacterial Pneumonia (DEFINE-CABP)
por: Horcajada, Juan P, et al.
Publicado: (2019)

Influenza and Bacterial Coinfection in Adults With Community-Acquired Pneumonia Admitted to Conventional Wards: Risk Factors, Clinical Features, and Outcomes
por: Abelenda-Alonso, Gabriela, et al.
Publicado: (2020)

Efficacy of Omadacycline Versus Moxifloxacin in the Treatment of Community-Acquired Bacterial Pneumonia by Disease Severity: Results From the OPTIC Study
por: Ramirez, Julio, et al.
Publicado: (2021)

A Statewide Collaborative Quality Initiative to Improve Antibiotic Duration and Outcomes in Patients Hospitalized With Uncomplicated Community-Acquired Pneumonia
por: Vaughn, Valerie M, et al.
Publicado: (2021)

Antibiotic Treatment Duration for Community-Acquired Pneumonia in Outpatient Children in High-Income Countries—A Systematic Review and Meta-Analysis
por: Kuitunen, Ilari, et al.
Publicado: (2022)

Electronic Health Record-Integrated Clinical Decision Support for Clinicians Serving Populations Facing Health Care Disparities: Literature Review
por: Stipelman, Carole H., et al.
Publicado: (2022)

Modified early warning score-based clinical decision support: cost impact and clinical outcomes in sepsis
por: Horton, Devin J, et al.
Publicado: (2020)

Non-ventilator associated hospital acquired pneumonia (NV-HAP) risk among hospitalized veterans before and during the COVID-19 pandemic
por: Carey, Evan, et al.
Publicado: (2023)

Etiology and Impact of Coinfections in Children Hospitalized With Community-Acquired Pneumonia
por: Nolan, Vikki G, et al.
Publicado: (2018)

Diabetes Reduces the Rate of Sputum Culture Conversion in Patients With Newly Diagnosed Multidrug-Resistant Tuberculosis
por: Salindri, Argita D., et al.
Publicado: (2016)

Pneumococcal Carriage, Serotype Distribution, and Risk Factors in Children With Community-Acquired Pneumonia, 5 Years After Introduction of the 10-Valent Pneumococcal Conjugate Vaccine in Ethiopia
por: Negash, Abel Abera, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_si7d4gi6usv1caoetp6m02hssn